Aileron Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
Initiated Phase 1b randomized, double-blind, placebo-controlled trial of ALRN-6924 in patients with advanced p53-mutated non-small…
Month: August 2021
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results
CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
WALTHAM, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or…
Panbela Provides Business Update and Reports Q2 2021 Financial Results
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update
Ended second quarter 2021 with $36.8 million in cash and cash equivalents On May 16,…
Zomedica Announces Second Quarter 2021 Financial Results
TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay Sales ANN ARBOR, Mich., Aug. 11,…
Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update
FOSTER CITY, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
Entasis Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
-Management to Host Conference Call on August 12 at 8am ET- Patient Enrollment in the…
Cyclacel Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
– Announces First Patients with Solid Tumors Dosed with Oral Fadraciclib –– Additional Phase 1/2…
Biomea Fusion Reports Second Quarter 2021 Financial Results and Business Highlights
Completed investigational new drug (“IND”) enabling studies for lead program, BMF-219, an irreversibly binding menin…
Atreca Reports Second Quarter 2021 Financial Results and Recent Corporate Developments
SAN CARLOS, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
Achieved Record Total Revenues of $17.8 Million in Second Quarter 2021, a 129% Increase Over…
Eyenovia Reports Second Quarter 2021 Financial Results
Announced positive topline data from its Phase 3 VISION-1 study evaluating MicroLine for the treatment…
Heat Biologics Provides Second Quarter 2021 Business Update
DURHAM, N.C., Aug. 11, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a…
Histogen Reports Second Quarter 2021 Earnings and Provides Business Update
Company to Focus its Regenerative Medicine Technology Platform on Developing Orthopedic Product Candidates Initiated Phase…
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021
BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) — Teligent, Inc. (Nasdaq: TLGT), (“Teligent” or the “Company”),…
GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
– Awarded $4.7 Million Government Grant Funding to support the building of a high-tech manufacturing facility…
TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 11, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
Yield10 Bioscience Announces Second Quarter 2021 Financial Results
Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results…
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
– Dosed First Patient in Phase 1/2 Clinical Trial of CFT7455, a novel IKZF1/3 Degrader,…